Literature DB >> 10929048

Fortifying B cells with CD154: an engaging tale of many hues.

J Gordon1, J D Pound.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10929048      PMCID： PMC2327028          DOI： 10.1046/j.1365-2567.2000.00074.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  77 in total

1.  Co-ligation of CD44 on naive human tonsillar B cells induces progression towards a germinal center phenotype.

Authors:  S Ingvarsson; K Dahlenborg; R Carlsson; C A Borrebaeck
Journal:  Int Immunol       Date:  1999-05       Impact factor: 4.823

2.  B cells turn off virgin but not memory T cells.

Authors:  E J Fuchs; P Matzinger
Journal:  Science       Date:  1992-11-13       Impact factor: 47.728

3.  Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells.

Authors:  J D Pound; A Challa; M J Holder; R J Armitage; S K Dower; W C Fanslow; H Kikutani; S Paulie; C D Gregory; J Gordon
Journal:  Int Immunol       Date:  1999-01       Impact factor: 4.823

4.  Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.

Authors:  K Wheeler; J D Pound; J Gordon; R Jefferis
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

5.  CD40 signaling induces B cell responsiveness to multiple members of the gamma chain-common cytokine family.

Authors:  P Griebel; T Beskorwayne; A Van den Broeke; G Ferrari
Journal:  Int Immunol       Date:  1999-07       Impact factor: 4.823

6.  Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.

Authors:  M J Holder; H Wang; A E Milner; M Casamayor; R Armitage; M K Spriggs; W C Fanslow; I C MacLennan; C D Gregory; J Gordon
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

7.  Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis.

Authors:  K A Knox; J Gordon
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

Review 8.  CD40 ligand and its role in X-linked hyper-IgM syndrome.

Authors:  R E Callard; R J Armitage; W C Fanslow; M K Spriggs
Journal:  Immunol Today       Date:  1993-11

9.  Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules.

Authors:  M H Kosco-Vilbois; D Gray; D Scheidegger; M Julius
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.

Authors:  F Ronchese; B Hausmann
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307
View more
  6 in total

Review 1.  In vivo maturation and migration of dendritic cells.

Authors:  L Flores-Romo
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  A potent adjuvant effect of CD40 antibody attached to antigen.

Authors:  Tom A Barr; Adele L McCormick; Jennifer Carlring; Andrew W Heath
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

Review 3.  Life and death within germinal centres: a double-edged sword.

Authors:  Liliana Guzman-Rojas; Jennifer C Sims-Mourtada; Roberto Rangel; Hector Martinez-Valdez
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 4.  Immunotherapy for lymphomas.

Authors:  John M Timmerman
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

5.  Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction.

Authors:  Jessie F Fecteau; Annie Roy; Sonia Néron
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

6.  The molecular mechanism in activation-induced cell death of an Ag-reactive B cell clone.

Authors:  T Hamano; T Iwasaki; A Ogata; N Hashimoto; E Kakishita
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.